Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


06.08.2018

8 Diabet Med
3 Diabetes
1 Intern Med
1 J Autoimmun
6 J Neurol
2 Lancet Neurol
1 Lancet Respir Med
2 Mult Scler
15 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Diabet Med

  1. CHARALAMPOPOULOS D, Amin R, Warner JT, Muniz-Terrera G, et al
    Clinic variation in glycaemic control for children with Type 1 diabetes in England and Wales: a population-based, multilevel analysis.
    Diabet Med. 2017 Aug 5. doi: 10.1111/dme.13442.
    PubMed     Text format     Abstract available

  2. CLERY P, Stahl D, Ismail K, Treasure J, et al
    Systematic review and meta-analysis of the efficacy of interventions for people with Type 1 diabetes mellitus and disordered eating.
    Diabet Med. 2017 Sep 8. doi: 10.1111/dme.13509.
    PubMed     Text format     Abstract available

  3. BROWNE JL, Ventura AD, Mosely K, Speight J, et al
    Measuring Type 1 diabetes stigma: development and validation of the Type 1 Diabetes Stigma Assessment Scale (DSAS-1).
    Diabet Med. 2017 Sep 11. doi: 10.1111/dme.13507.
    PubMed     Text format     Abstract available

  4. LINDNER LME, Rathmann W, Rosenbauer J
    Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio-economic status and area-level deprivation in Type 1 diabetes mellitus: a systematic review.
    Diabet Med. 2017 Sep 25. doi: 10.1111/dme.13519.
    PubMed     Text format     Abstract available

  5. BREUKER C, Macioce V, Mura T, Audurier Y, et al
    Medication errors at hospital admission and discharge in Type 1 and 2 diabetes.
    Diabet Med. 2017 Oct 19. doi: 10.1111/dme.13531.
    PubMed     Text format     Abstract available

  6. MARJOT T, Sbardella E, Moolla A, Hazlehurst JM, et al
    Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital.
    Diabet Med. 2018;35:89-98.
    PubMed     Text format     Abstract available

  7. EVANS-CHEUNG TC, Bodansky HJ, Parslow RC, Feltbower RG, et al
    Mortality and acute complications in children and young adults diagnosed with Type 1 diabetes in Yorkshire, UK: a cohort study.
    Diabet Med. 2017 Nov 7. doi: 10.1111/dme.13544.
    PubMed     Text format     Abstract available

  8. HEALD AH, Livingston M, Fryer A, Moreno GYC, et al
    Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.
    Diabet Med. 2017 Nov 9. doi: 10.1111/dme.13541.
    PubMed     Text format     Abstract available


    Diabetes

  9. SINGER RA, Sussel L
    Islet Long Noncoding RNAs: A Playbook for Discovery and Characterization.
    Diabetes. 2018;67:1461-1470.
    PubMed     Text format     Abstract available

  10. STAMATOULI AM, Quandt Z, Perdigoto AL, Clark PL, et al
    Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.
    Diabetes. 2018 Jun 24. pii: dbi18-0002. doi: 10.2337/dbi18-0002.
    PubMed     Text format     Abstract available

  11. CREUSOT RJ, Postigo-Fernandez J, Teteloshvili N
    Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
    Diabetes. 2018;67:1481-1494.
    PubMed     Text format     Abstract available


    Intern Med

  12. TAJIMA Y, Matsumura M, Yaguchi H, Mito Y, et al
    Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy.
    Intern Med. 2018;57:867-871.
    PubMed     Text format     Abstract available


    J Autoimmun

  13. NAHAL SK, Selmi C, Gershwin ME
    Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.
    J Autoimmun. 2018 Jul 27. pii: S0896-8411(18)30280.
    PubMed     Text format     Abstract available


    J Neurol

  14. ALENDA R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, et al
    Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.
    J Neurol. 2018;265:24-31.
    PubMed     Text format     Abstract available

  15. COCOZZA S, Pontillo G, Russo C, Russo CV, et al
    Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy?
    J Neurol. 2018 Jul 28. pii: 10.1007/s00415-018-8985.
    PubMed     Text format     Abstract available

  16. FROHLICH K, Winder K, Linker RA, Huhn K, et al
    Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.
    J Neurol. 2018 Jul 31. pii: 10.1007/s00415-018-8989.
    PubMed     Text format     Abstract available

  17. MCMACKEN G, Whittaker RG, Evangelista T, Abicht A, et al
    Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.
    J Neurol. 2018;265:194-203.
    PubMed     Text format     Abstract available

  18. BALLOY G, Pelletier J, Suchet L, Lebrun C, et al
    Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
    J Neurol. 2018 Jul 27. pii: 10.1007/s00415-018-8984.
    PubMed     Text format     Abstract available

  19. BARONE S, Caligiuri ME, Valentino P, Cherubini A, et al
    Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    J Neurol. 2018 Jul 26. pii: 10.1007/s00415-018-8980.
    PubMed     Text format     Abstract available


    Lancet Neurol

  20. GELFAND JM
    Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis.
    Lancet Neurol. 2018 Jul 23. pii: S1474-4422(18)30279.
    PubMed     Text format    

  21. ARMANGUE T, Spatola M, Vlagea A, Mattozzi S, et al
    Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
    Lancet Neurol. 2018 Jul 23. pii: S1474-4422(18)30244.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  22. RONSMANS S, Nemery B
    The presence of autoimmune antibodies in pulmonary alveolar proteinosis does not necessarily imply idiopathic disease.
    Lancet Respir Med. 2018 Jul 26. pii: S2213-2600(18)30299.
    PubMed     Text format    


    Mult Scler

  23. BHAN A, Jacobsen C, Myhr KM, Dalen I, et al
    Neurofilaments and 10-year follow-up in multiple sclerosis.
    Mult Scler. 2018 Aug 1:1352458518782005. doi: 10.1177/1352458518782005.
    PubMed     Text format     Abstract available

  24. YANG R, Dunn JF
    Multiple sclerosis disease progression: Contributions from a hypoxia-inflammation cycle.
    Mult Scler. 2018 Jul 27:1352458518791683. doi: 10.1177/1352458518791683.
    PubMed     Text format     Abstract available


    PLoS One

  25. STORM FA, Nair KPS, Clarke AJ, Van der Meulen JM, et al
    Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    PLoS One. 2018;13:e0196463.
    PubMed     Text format     Abstract available

  26. DE SANTIAGO L, Sanchez-Morla E, Blanco R, Miguel JM, et al
    Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLoS One. 2018;13:e0194964.
    PubMed     Text format     Abstract available

  27. CIURLEO R, Bonanno L, De Salvo S, Romeo L, et al
    Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
    PLoS One. 2018;13:e0196006.
    PubMed     Text format     Abstract available

  28. SANCHEZ-DALMAU B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, et al
    Predictors of vision impairment in Multiple Sclerosis.
    PLoS One. 2018;13:e0195856.
    PubMed     Text format     Abstract available

  29. MASUDA K, Tanabe K, Ujike H, Hinamoto N, et al
    Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    PLoS One. 2018;13:e0195779.
    PubMed     Text format     Abstract available

  30. DESHAYES S, Aouba A, Khoy K, Mariotte D, et al
    Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis.
    PLoS One. 2018;13:e0195680.
    PubMed     Text format     Abstract available

  31. LIN Y, Liu L, Sheng Y, Shen C, et al
    A catalog of potential putative functional variants in psoriasis genome-wide association regions.
    PLoS One. 2018;13:e0196635.
    PubMed     Text format     Abstract available

  32. CECCARELLI F, Perricone C, Pirone C, Massaro L, et al
    Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
    PLoS One. 2018;13:e0196103.
    PubMed     Text format     Abstract available

  33. HANAOKA H, Iida H, Kiyokawa T, Takakuwa Y, et al
    Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
    PLoS One. 2018;13:e0196172.
    PubMed     Text format     Abstract available

  34. WITHER JE, Prokopec SD, Noamani B, Chang NH, et al
    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.
    PLoS One. 2018;13:e0196117.
    PubMed     Text format     Abstract available

  35. KRAAL LJN, Nijland ML, Germar KL, Baeten DLP, et al
    Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.
    PLoS One. 2018;13:e0197219.
    PubMed     Text format     Abstract available

  36. FERNANDEZ O, Izquierdo G, Fernandez V, Leyva L, et al
    Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
    PLoS One. 2018;13:e0195891.
    PubMed     Text format     Abstract available

  37. NWOSU BU, Zhang B, Ayyoub SS, Choi S, et al
    Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    PLoS One. 2018;13:e0196912.
    PubMed     Text format     Abstract available

  38. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Text format     Abstract available

  39. WUERFEL E, Weddige A, Hagmayer Y, Jacob R, et al
    Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    PLoS One. 2018;13:e0194873.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. RUSSI AE, Ebel ME, Yang Y, Brown MA, et al
    Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.
    Proc Natl Acad Sci U S A. 2018;115:E1520-E1529.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: